Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online October 13, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0201v1
24/2/333    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blocklet, D.
Right arrow Articles by Goldman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blocklet, D.
Right arrow Articles by Goldman, S.
Submitted on May 4, 2005
Accepted on October 3, 2005

Rapid Communication

Myocardial homing of non mobilized peripheral-blood CD34+ cells after intra-coronary injection

Didier Blocklet 1*, Michel Toungouz 1, Guy Berkenboom 1, Micheline Lambermont 1, Philippe Unger 1, Nicolas Preumont 1, Eric Stoupel 1, Dominique Egrise 1, Jean-Paul Degaute 1, Michel Goldman 1, Serge Goldman 1

1 U.L.B. Hôpital Universitaire Erasme, Brussels, Belgium

* To whom correspondence should be addressed. E-mail: dblockle{at}ulb.ac.be.


   Abstract

Granulocyte-colony stimulating factor administered for autologous hematopoietic stem cells (HSC) isolation from blood may favour restenosis in patients implanted after acute myocardial infarction (AMI). We therefore tested the isolation of peripheral-blood CD34+ cells without mobilisation in six patients with AMI. After large-volume cytapheresis and positive CD34+ cells selection, 3.6 to 27.6 millions CD34+ cells were obtained. We performed intra-coronary implantation of these cells and recorded no restenosis or arrhythmia. We used PET to assess myocardial labelled-CD34+ cell homing, which accounted for 5.5% of injected cells one hour post-implantation. In conclusion, large amounts of CD34+ cells, in the range reported in previous studies, can be obtained from non-mobilized peripheral blood. PET with FDG cell labelling is an efficient imaging method for homing assessment.




This article has been cited by other articles:


Home page
HeartHome page
M Penicka, O Lang, P Widimsky, P Kobylka, T Kozak, T Vanek, J Dvorak, J Tintera, and J Bartunek
One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction
Heart, July 1, 2007; 93(7): 837 - 841.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Goussetis, A. Manginas, M. Koutelou, I. Peristeri, M. Theodosaki, N. Kollaros, E. Leontiadis, A. Theodorakos, G. Paterakis, G. Karatasakis, et al.
Intracoronary Infusion of CD133+ and CD133-CD34+ Selected Autologous Bone Marrow Progenitor Cells in Patients with Chronic Ischemic Cardiomyopathy: Cell Isolation, Adherence to the Infarcted Area, and Body Distribution
Stem Cells, October 1, 2006; 24(10): 2279 - 2283.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Oettgen
Cardiac Stem Cell Therapy: Need for Optimization of Efficacy and Safety Monitoring
Circulation, July 25, 2006; 114(4): 353 - 358.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2005 by AlphaMed Press.